The 2010 global proficiency study of human papillomavirus genotyping in vaccinology

Journal of Clinical Microbiology

Volumn 50, Issue 7, 2012, Pages 2289-2298

  Eklund, Carina ^a,b   Forslund, Ola ^a   Wallin, Keng Ling ^c   Zhou, Tiequn ^d   Dillner, Joakim ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c EQUALIS AB   (Sweden)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; WART VIRUS VACCINE;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DRUG SCREENING; FALSE POSITIVE RESULT; GENETIC PROCEDURES; GENOTYPING TECHNIQUE; GOOD LABORATORY PRACTICE; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68A; HUMAN PAPILLOMAVIRUS TYPE 68B; MICROARRAY ANALYSIS; MIXED INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPILLOMAVIRUS INFECTION; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; VACCINATION; VIRUS DETECTION; VIRUS EXAMINATION; WART VIRUS;

FEMALE; GENOTYPE; HUMANS; INTERNATIONAL COOPERATION; LABORATORY PROFICIENCY TESTING; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; VIROLOGY;

EID: 84862751797     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00840-12     Document Type: Article

References (39)

1. Baay MF, et al. 1996. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J. Clin. Microbiol. 34:745-747.
2. Bernard HU, et al. 1994. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J. Infect. Dis. 170:1077-1085.
3. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. 2002. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55:244-265.
4. Chouhy D, et al. 2006. Development and evaluation of a colorimetric PCR system for the detection and typing of human papillomaviruses. Int. J. Mol. Med. 18:995-1003.
5. Coutlee F, et al. 2007. Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the Linear Array HPV genotyping test. J. Clin. Microbiol. 45:3821-3823.
6. Eklund C, Zhou T, Dillner J. 2010. Global proficiency study of human papillomavirus genotyping. J. Clin. Microbiol. 48:4147-4155.
7. Else EA, et al. 2011. Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with INNO-LiPA HPV genotyping extra assay. J. Clin. Microbiol. 49:1907-1912.
8. Estrade C, Menoud PA, Nardelli-Haefliger D, Sahli R. 2011. Validation of a low-cost human papillomavirus genotyping assay based on PGMY PCR and reverse blotting hybridization with reusable membranes. J. Clin. Microbiol. 49:3474-3481.
9. Ferguson M, Wilkinson DE, Zhou T. 2009. WHO meeting on the standardization of HPV assays and the role of the WHO HPV Laboratory Network in supporting vaccine introduction held on 24-25 January 2008, Geneva, Switzerland. Vaccine 27:337-347.
10. Gheit T, et al. 2006. Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J. Clin. Microbiol. 44:2025-2031.
11. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. 1998. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J. Clin. Microbiol. 36:3020-3027.
12. Jacobs MV, et al. 1995. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J. Clin. Microbiol. 33:901-905.
13. Kim KH, et al. 2006. Development and evaluation of a highly sensitive human papillomavirus genotyping DNA chip. Gynecol. Oncol. 100:38-43.
14. Kleter B, et al. 1999. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37:2508-2517.
15. Klug SJ, et al. 2008. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. J. Med. Virol. 80:1264-1274.
16. Kocjan BJ, Poljak M, Seme K. 2010. Universal ProbeLibrary based realtime PCR assay for detection and confirmation of human papillomavirus genotype 52 infections. J. Virol. Methods 163:492-494.
17. Liu SS, Leung RC, Chan KK, Cheung AN, Ngan HY. 2010. Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche Linear Array HPV genotyping assay. J. Clin. Microbiol. 48:758-764.
18. Longuet M, Beaudenon S, Orth G. 1996. Two novel genital human papillomavirus (HPV) types, HPV68 and HPV70, related to the potentially oncogenic HPV39. J. Clin. Microbiol. 34:738-744.
19. Meijer CJ, et al. 2009. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int. J. Cancer 124:516-520.
20. Nazarenko I, et al. 2008. A novel method of HPV genotyping using Hybrid Capture sample preparation method combined with GP5+/6+ PCR and multiplex detection on Luminex XMAP. J. Virol. Methods 154:76-81.
21. Nishiwaki M, et al. 2008. Genotyping of human papillomaviruses by a novel one-step typing method with multiplex PCR and clinical applications. J. Clin. Microbiol. 46:1161-1168.
22. Resnick RM, et al. 1990. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J. Natl. Cancer Inst. 82:1477-1484.
23. Reuter S, Delius H, Kahn T, Hofmann B, Hzur Hausen Schwarz E. 1991. Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell line ME180. J. Virol. 65:5564-5568.
24. Roberts CC, Swoyer R, Bryan JT, Taddeo FJ. 2011. Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with the Linear Array HPV genotyping PCR assay and influence of DNA extraction method on HPV detection. J. Clin. Microbiol. 49:1899-1906.
25. Schmitt M, et al. 2006. Bead-based multiplex genotyping of human papillomaviruses. J. Clin. Microbiol. 44:504-512.
26. Schmitt M, Dondog B, Waterboer T, Pawlita M. 2008. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers. J. Clin. Microbiol. 46:1050-1059.
27. Smith JS, et al. 2007. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int. J. Cancer 121:621-632.
28. Snijders PJ, et al. 2006. Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33-positive women with normal cytology. Int. J. Cancer 119:1102-1107.
29. Soderlund-Strand A, Carlson J, Dillner J. 2009. Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus. J. Clin. Microbiol. 47:541-546.
30. Sotlar K, et al. 2004. Detection and typing of human papillomavirus by e6 nested multiplex PCR. J. Clin. Microbiol. 42:3176-3184.
31. Stambos V, et al. 2011. Evaluation of the World Health Organization global measles and rubella quality assurance program, 2001-2008. J. Infect. Dis. 204(Suppl 1):S499-S505.
32. Stevens MP, Garland SM, Tabrizi SN. 2008. Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler 480 system. J. Virol. Methods 147:290-296.
33. Tucker RA, Unger ER, Holloway BP, Swan DC. 2001. Real-time PCR-based fluorescent assay for quantitation of human papillomavirus types 6, 11, 16, and 18. Mol. Diagn. 6:39-47.
34. van den Brule AJ, et al. 2002. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J. Clin. Microbiol. 40:779-787.
35. Walboomers JM, et al. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
36. WHO. 2009. Human papillomavirus laboratory manual, 1st ed. WHO, Geneva, Switzerland.
37. WHO. 2006, posting date. Initiative for vaccine research. Human papillomavirus. WHO, Geneva, Switzerland. http://www.who.int/biologicals/ publications/trs/areas/vaccines/human-papillomavirus/ HPVg%20Final%20BS%202050%20.pdf.
38. WHO. 2005, posting date. WHO technical workshop on the role of laboratory detection of human papillomavirus in global disease prevention and control. World Health Organization, Geneva, Switzerland. http://www.who.int/biologicals/ vaccines/hpv/en/index.html.
39. Wilkinson DE, et al. 2010. Establishment of the 1(st) world health organization international standards for human papillomavirus type 16 DNA and type 18 DNA. Int. J. Cancer 126:2969-2983.